Keyword: Twist Bioscience
Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.
Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”
California life sciences companies Twist Bioscience and LakePharma have penned a new pact to offer antibody discovery services to biopharma clients.
Celgene brings on Keytruda R&D exec Alise Reicin in shake-up; IBM Watson Health chief Deborah DiSanzo steps down; and AbbVie CFO Bill Chase to retire.
Former Aravive Chairman Ray Tabibiazar will serve as senior vice president of corporate development and business strategy at Twist Bioscience.
Twist Bioscience has paired its DNA synthesis capabilities to Desktop Genetics' synthetic guide RNA CRISPR design software,
Microsoft has ordered 10 million strands of synthetic DNA from Twist Bioscience to support research into the storage of digital data on DNA.
Synthetic DNA player Twist Bioscience has expanded its software capabilities ahead of the build-out of its e-commerce platform.